封面
市场调查报告书
商品编码
1566223

益智药市场规模、份额、成长分析、按格式、分销管道、按地区 - 产业预测,2024-2031

Nootropics Market Size, Share, Growth Analysis, By Form (Capsules/Tablets, Powder), By Distribution Channel (Online, Offline), By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球促智药市场规模为37.7亿美元,从2023年的43.2亿美元成长到2031年的128.7亿美元,预测期(2024-2031)预计复合年增长率为14.62%。

促智药市场涵盖各种旨在改善记忆力、创造力和注意力等心理功能的认知增强剂,并且由于各个领域的消费者需求不断增长,该市场正在经历显着增长。天然和合成化合物,包括咖啡因、人参和Modafinil,透过促进大脑的血液流动、增加神经传导物质水平和保护神经细胞健康而发挥作用,使其在这一领域发挥着极其重要的作用。然而,某些促智药的长期影响仍不清楚,这凸显了在医疗监督下使用这些物质的重要性。在美国,综合维他命片也有双重用途,因为成年人经常使用它们来改善认知功能,例如注意力和警觉性。智慧医疗的日益普及也反映在 Dualdiagnosis.org 等资讯来源报告的趋势中,突显了增强心理能力的社会趋势。学生和专业人士对智慧药物的广泛接受进一步推动了这个市场的扩张,强调将认知增强剂纳入日常生活时需要仔细考虑。总体而言,在人们对精神敏锐度和生产力提高的追求的推动下,促智药市场是一个快速成长的领域,具有广阔的成长机会。

目录

介绍

  • 研究目的
  • 定义
  • 市场范围

调查方法

  • 资讯采购
  • 二手资料来源和主要资料来源
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 市场概况展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 监管环境
  • 价值链分析
  • 主要客户及采购标准分析

促智药市场:依形式分类

  • 介绍
  • 胶囊/锭剂
  • 粉末
  • 其他的

促智药市场:按分销管道

  • 介绍
  • 离线
  • 在线的

促智药市场规模:依地区划分

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲 (MEA)
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲地区

竞争格局

  • 前5名企业对比
  • 主要企业市场定位(2023年)
  • 主要市场参与者所采取的策略
  • 近期市集活动
  • 主要企业市场占有率(2023年)

主要企业简介

  • Onnit Labs, Inc.
  • Reckitt Benckiser Group PLC
  • Mental Mojo, LLC
  • NooCube
  • Mind Lab Pro(Performance Lab Group Ltd)
  • TruBrain
  • Zhou Nutrition
  • Kimera Koffee
  • Purelife Bioscience Co. Ltd.
  • Nootrobox Inc.
  • Nootropic Source
  • AlternaScript LLC
  • HVMN Inc.
  • Powder City LLC
  • Nootropics Depot LLC
  • Peak Nootropics
  • Nootropic Geek LLC
  • Mind Nutrition Ltd.
  • Neurofuse Inc.
  • BrainMD Health
简介目录
Product Code: SQMIG35A2160

Global Nootropics Market size was valued at USD 3.77 billion in 2022 and is poised to grow from USD 4.32 billion in 2023 to USD 12.87 billion by 2031, growing at a CAGR of 14.62% during the forecast period (2024-2031).

The nootropics market, encompassing a range of cognitive enhancers aimed at improving mental functions such as memory, creativity, and focus, is witnessing significant growth driven by increased consumer demand across various demographics. Both natural and synthetic compounds, including caffeine, ginseng, and modafinil, play a pivotal role in this space, functioning by enhancing blood flow to the brain, elevating neurotransmitter levels, and protecting neuronal health. Students, professionals, and athletes are increasingly drawn to these enhancements to optimize their cognitive performance; however, the long-term effects of certain nootropics remain uncertain, underscoring the importance of using these substances under medical supervision. In the U.S., multivitamin tablets also serve a dual purpose, as adults often turn to them for improved cognitive functions like concentration and alertness. The rising popularity of smart medications is reflected in trends reported in sources such as dualdiagnosis.org, highlighting a growing societal inclination toward enhancing mental capacity. This market expansion is further fueled by the widespread acceptance of smart pharmaceuticals among students and professionals alike, emphasizing the need for careful consideration when integrating cognitive enhancers into daily routines. Overall, the nootropics market represents a burgeoning sector with promising growth opportunities, driven by the increasing pursuit of mental acuity and productivity enhancement.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nootropics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nootropics Market Segmental Analysis

Global Nootropics Market is segmented by Form, Distribution Channel, and region. Based on Form, the market is segmented into Capsules/Tablets, Powder, Drinks, Others. Based on Distribution Channel, the market is segmented into Online, Offline. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nootropics Market

The global nootropics market is significantly driven by the escalating demand for cognitive enhancers, particularly among students and working professionals facing intense academic and occupational pressures. As competition rises, individuals increasingly seek solutions to enhance cognitive functions such as memory retention, creativity, and focus. Nootropics emerge as a viable option, offering benefits that boost brain performance and improve mental clarity, thereby enabling users to meet their demands effectively. Additionally, the rising prevalence of age-related cognitive decline among the elderly is further fueling market growth, as this demographic increasingly turns to nootropics to maintain cognitive health and enhance quality of life.

Restraints in the Global Nootropics Market

The global nootropics market faces significant restraints primarily due to the absence of standardization and regulatory oversight within the industry. Many nootropic substances lack approval from regulatory bodies, like the FDA, leading to heightened safety concerns among potential consumers. The unclear long-term effects of various nootropics exacerbate these apprehensions, deterring users from integrating them into their daily routines. Furthermore, inconsistencies in standardized dosages and quality control during manufacturing contribute to uncertainty regarding the effectiveness and safety of these products, undermining consumer confidence and hindering market growth in an increasingly health-conscious environment.

Market Trends of the Global Nootropics Market

The global nootropics market is poised for substantial expansion, driven by a rising appetite for cognitive enhancers from diverse demographics, including students, professionals, and the aging population. A notable trend is the increasing preference for natural and herbal nootropics as consumers prioritize health and wellness. As innovation fuels product development, companies are introducing cutting-edge supplements tailored to enhance cognitive function, further propelling market growth. However, this burgeoning sector faces challenges such as regulatory inconsistencies and a lack of standardization, which could undermine consumer trust and potentially hinder market progression in the near future.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Regulatory Landscape
  • Value Chain Analysis
  • Key Customer and buying Criteria Analysis

Nootropics Market, By Form

  • Introduction
  • Capsules/Tablets
  • Powder
  • Drinks
  • Others

Nootropics Market, By Distribution Channel

  • Introduction
  • Offline
  • Online

Nootropics Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Onnit Labs, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Reckitt Benckiser Group PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mental Mojo, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NooCube
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mind Lab Pro (Performance Lab Group Ltd)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TruBrain
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zhou Nutrition
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kimera Koffee
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Purelife Bioscience Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nootrobox Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nootropic Source
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AlternaScript LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HVMN Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Powder City LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nootropics Depot LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Peak Nootropics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nootropic Geek LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mind Nutrition Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neurofuse Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BrainMD Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments